FindTrial
Sign In

Contrast-enhanced ultrasonography of hepatic inflammatory pseudotumor

Contrast-enhanced ultrasonography of hepatic inflammatory pseudotumor

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078518
Enrollment
Unknown
Registered
2023-12-11
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic inflammatory pseudotumor

Interventions

Gold Standard:Pathological results
Index test:The degree and pattern of enhancement, enhancement morphology, and other characteristics of arterial phase, portal phase, and delayed phase contrast-enhanced ultrasound in HIPT

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who underwent contrast-enhanced ultrasound and were pathologically confirmed to have inflammatory pseudotumors of the liver.

Exclusion criteria

Exclusion criteria: Cases of poor image quality and incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Enhancement characteristics of HIPT;Diagnostic accordance rate;—

Countries

China

Contacts

Public ContactLu Qiang

West China Hospital of Sichuan University

luqiang@scu.edu.cn+86 138 8217 5090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026